COPD and its comorbidities: Impact, measurement and mechanisms

被引:355
作者
Negewo, Netsanet A. [1 ,2 ]
Gibson, Peter G. [1 ,2 ,3 ]
McDonald, Vanessa M. [1 ,2 ,3 ,4 ]
机构
[1] Univ Newcastle, Fac Hlth & Med, Prior Res Ctr Asthma & Resp Dis, Callaghan, NSW 2308, Australia
[2] Univ Newcastle, Fac Hlth & Med, Hunter Med Res Inst, Callaghan, NSW 2308, Australia
[3] John Hunter Hosp, Dept Resp & Sleep Med, Newcastle, NSW, Australia
[4] Univ Newcastle, Sch Nursing & Midwifery, Callaghan, NSW 2308, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
chronic obstructive pulmonary disease; comorbidity; multi-morbidity; prognostic index; OBSTRUCTIVE PULMONARY-DISEASE; MULTIDIMENSIONAL PROGNOSTIC INDEXES; HEALTH-CARE UTILIZATION; SYSTEMIC INFLAMMATION; BODE INDEX; LUNG-DISEASE; BETA-BLOCKERS; HEART-DISEASE; RISK-FACTORS; MORTALITY;
D O I
10.1111/resp.12642
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
100201 [内科学];
摘要
Chronic obstructive pulmonary disease (COPD) frequently coexists with other conditions often known as comorbidities. The prevalence of most of the common comorbid conditions that accompany COPD has been widely reported. It is also recognized that comorbidities have significant health and economic consequences. Nevertheless, there is scant research examining how comorbidities should be assessed and managed in the context of COPD. Also, the underlying mechanisms linking COPD with its comorbidities are still not fully understood. Owing to these knowledge gaps, current disease-specific approaches provide clinicians with little guidance in terms of managing comorbid conditions in the clinical care of multi-diseased COPD patients. This review discusses the concepts of comorbidity and multi-morbidity in COPD in relation to the overall clinical outcome of COPD management. It also summarizes some of the currently available clinical scores used to measure comorbid conditions and their prognostic abilities. Furthermore, recent developments in the proposed mechanisms linking COPD with its comorbidities are discussed.
引用
收藏
页码:1160 / 1171
页数:12
相关论文
共 103 条
[1]
Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort [J].
Agusti, Alvar ;
Edwards, Lisa D. ;
Celli, Bartolome ;
MacNee, William ;
Calverley, Peter M. A. ;
Muellerova, Hana ;
Lomas, David A. ;
Wouters, Emiel ;
Bakke, Per ;
Rennard, Steve ;
Crim, Courtney ;
Miller, Bruce E. ;
Coxson, Harvey O. ;
Yates, Julie C. ;
Tal-Singer, Ruth ;
Vestbo, Jorgen .
EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (03) :636-646
[2]
The COPD control panel: towards personalised medicine in COPD [J].
Agusti, Alvar ;
MacNee, William .
THORAX, 2013, 68 (07) :687-690
[3]
Characterisation of COPD heterogeneity in the ECLIPSE cohort [J].
Agusti, Alvar ;
Calverley, Peter M. A. ;
Celli, Bartolome ;
Coxson, Harvey O. ;
Edwards, Lisa D. ;
Lomas, David A. ;
MacNee, William ;
Miller, Bruce E. ;
Rennard, Steve ;
Silverman, Edwin K. ;
Tal-Singer, Ruth ;
Wouters, Emiel ;
Yates, Julie C. ;
Vestbo, Jorgen .
RESPIRATORY RESEARCH, 2010, 11
[4]
Short- and Medium-term Prognosis in Patients Hospitalized for COPD Exacerbation The CODEX Index [J].
Almagro, Pedro ;
Soriano, Joan B. ;
Cabrera, Francisco J. ;
Boixeda, Ramon ;
Alonso-Ortiz, M. Belen ;
Barreiro, Bienvenido ;
Diez-Manglano, Jesus ;
Murio, Cristina ;
Heredia, Josep L. .
CHEST, 2014, 145 (05) :972-980
[5]
Comorbidities and Short-term Prognosis in Patients Hospitalized for Acute Exacerbation of COPD The EPOC en Servicios de Medicina Interna (ESMI) Study [J].
Almagro, Pedro ;
Javier Cabrera, Francisco ;
Diez, Jesus ;
Boixeda, Ramon ;
Alonso Ortiz, M. Belen ;
Murio, Cristina ;
Soriano, Joan B. .
CHEST, 2012, 142 (05) :1126-1133
[6]
[Anonymous], COPDX PLAN AUSTR NZ
[7]
[Anonymous], EUR RESP J S55
[8]
[Anonymous], 2015, Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease
[9]
Systemic manifestations and comorbidities of COPD [J].
Barnes, P. J. ;
Celli, B. R. .
EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (05) :1165-1185